4-Methylmorpholine → HCID 178502721, compound
Reaction equation
[C:1]([O:5][C:6]([NH:8][CH2:9][C@H:10]1[CH2:15][CH2:14][C@H:13]([C:16]([OH:18])=O)[CH2:12][CH2:11]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl.[CH3:20][NH:21][O:22][CH3:23].CN1CCOCC1.CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1>C(Cl)Cl>[C:1]([O:5][C:6](=[O:7])[NH:8][CH2:9][C@H:10]1[CH2:11][CH2:12][C@H:13]([C:16](=[O:18])[N:21]([O:22][CH3:23])[CH3:20])[CH2:14][CH2:15]1)([CH3:2])([CH3:3])[CH3:4]Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 81 g (314.77 mmol) trans-4-[(tert-Butoxyformamido)methyl]cyclohexanecarboxylic acid in 4 l CH2Cl2 was treated with 50.13 g (503.63 mmol) N,O-dimethyl-hydroxylamine hydrochloride, 55.37 ml (503.63 mmol) N-methylmorpholine and at 0° C. with 78.45 g (409.2 mmol) EDCI and 9.67 g (62.95 mmol) HOBT. The reaction mixture was stirred 16 h at room temperature, evaporated and extracted with aqueous 10% KHSO4/Et2O (3×). The organic phases were washed with aqueous saturated NaHCO3, 10% NaCl and dried over Na2SO4 to yield 100.03 g (quantitative) of trans-[4-(Methoxy-methyl-carbamoyl)-cyclohexylmethyl]-carbamic acid tert-butyl ester, MS: 301 (MH+).
Workup
- customevaporated
- extractionextracted with aqueous 10% KHSO4/Et2O (3×)
- washThe organic phases were washed with aqueous saturated NaHCO3, 10% NaCl
- dry with materialdried over Na2SO4
Sources & evidence
- ORD record
- ord-ee694bc821cd439086c9bedccb9474f5
- Source dataset
- uspto-grants-2006_03
- Patent number
- US07012077B2
Reaction notes
Loading…